SCI Pharmtech, Inc. (TPE: 4119)
Taiwan
· Delayed Price · Currency is TWD
84.80
+0.60 (0.71%)
Jan 20, 2025, 1:30 PM CST
SCI Pharmtech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 484.24 | 294.72 | 308.78 | 55.7 | 360.12 | 571.1 | Upgrade
|
Depreciation & Amortization | 216.93 | 145.29 | 90.61 | 63.71 | 133.3 | 136.73 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.58 | 0.58 | 1.33 | - | - | 1.67 | Upgrade
|
Loss (Gain) From Sale of Investments | -1.07 | 1.87 | 14.07 | -2.24 | 15.71 | -7.64 | Upgrade
|
Loss (Gain) on Equity Investments | 19.21 | 13.84 | 12.56 | 13.55 | - | - | Upgrade
|
Stock-Based Compensation | 18.72 | 18.72 | - | - | - | - | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | - | -1.18 | - | Upgrade
|
Other Operating Activities | 30.36 | 64.17 | -22.27 | -111.43 | 495 | 17.52 | Upgrade
|
Change in Accounts Receivable | -55.54 | -133.8 | -90.59 | 254.77 | 15.83 | 38.51 | Upgrade
|
Change in Inventory | -96.19 | -16.1 | -219.25 | 86.7 | -29.36 | -24.01 | Upgrade
|
Change in Accounts Payable | 31.41 | -4.39 | 14.86 | -47.1 | -13.42 | 5.15 | Upgrade
|
Change in Unearned Revenue | 22.37 | 6.59 | -9.99 | -55.53 | 38.2 | 28.69 | Upgrade
|
Change in Other Net Operating Assets | -574.9 | -175.74 | 196.45 | 22.15 | -42.68 | 23.86 | Upgrade
|
Operating Cash Flow | 96.11 | 215.77 | 296.57 | 280.28 | 971.53 | 791.6 | Upgrade
|
Operating Cash Flow Growth | -60.76% | -27.24% | 5.81% | -71.15% | 22.73% | 64.85% | Upgrade
|
Capital Expenditures | -793 | -1,029 | -1,168 | -771.03 | -217.7 | -199.51 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 0.07 | - | 0.07 | - | Upgrade
|
Sale (Purchase) of Intangibles | - | - | - | -3.95 | - | -4.98 | Upgrade
|
Investment in Securities | 43.57 | 163.27 | 156.03 | 237.42 | -217.64 | -63.28 | Upgrade
|
Other Investing Activities | - | -0.11 | 2.4 | -2 | 6.27 | 4.29 | Upgrade
|
Investing Cash Flow | -749.43 | -866.2 | -1,009 | -539.56 | -428.99 | -263.47 | Upgrade
|
Short-Term Debt Issued | - | 63 | 112 | - | - | - | Upgrade
|
Long-Term Debt Issued | - | 430.81 | 435.77 | - | - | - | Upgrade
|
Total Debt Issued | 294.67 | 493.81 | 547.77 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -1.89 | -1.65 | -1.77 | -2.05 | -1.91 | Upgrade
|
Total Debt Repaid | -76.15 | -1.89 | -1.65 | -1.77 | -2.05 | -1.91 | Upgrade
|
Net Debt Issued (Repaid) | 218.53 | 491.91 | 546.12 | -1.77 | -2.05 | -1.91 | Upgrade
|
Issuance of Common Stock | 957.6 | 957.6 | - | - | - | - | Upgrade
|
Common Dividends Paid | -149.39 | -23.85 | - | -39.74 | -461.01 | -333.84 | Upgrade
|
Other Financing Activities | - | - | 1 | - | - | - | Upgrade
|
Financing Cash Flow | 1,027 | 1,426 | 547.12 | -41.52 | -463.06 | -335.75 | Upgrade
|
Net Cash Flow | 373.42 | 775.23 | -165.4 | -300.8 | 79.47 | 192.37 | Upgrade
|
Free Cash Flow | -696.89 | -813.59 | -871.02 | -490.75 | 753.83 | 592.09 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | 27.32% | 77.62% | Upgrade
|
Free Cash Flow Margin | -49.31% | -67.57% | -96.81% | -56.79% | 28.03% | 25.13% | Upgrade
|
Free Cash Flow Per Share | -5.87 | -7.42 | -8.10 | -4.56 | 6.98 | 5.47 | Upgrade
|
Cash Interest Paid | 6 | 6.29 | 1.07 | 0.04 | 0.04 | 0.05 | Upgrade
|
Cash Income Tax Paid | 72.16 | 4.93 | 0.11 | 115.85 | 166.79 | 122.54 | Upgrade
|
Levered Free Cash Flow | -1,018 | -1,198 | -1,165 | -458.68 | 741.87 | 392.86 | Upgrade
|
Unlevered Free Cash Flow | -1,015 | -1,194 | -1,165 | -458.65 | 741.9 | 392.9 | Upgrade
|
Change in Net Working Capital | 557.14 | 428.71 | 162.21 | -206.58 | -169.06 | -24.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.